Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • FREELIMS’ Latest Version Offers a Comprehensive Suite of Features to Digitally Transform Labs and Meet Compliance

    May 5, 2023, 16:29 PM by
    The latest version of FreeLIMS, a Laboratory Information Management System (LIMS), offers a comprehensive suite of features to digitally transform labs and meet compliance.
    Full story
  • Qlucore launches new Omics Explorer version - up to 900 times faster

    May 5, 2023, 16:29 PM by
    Nasdaq First North-listed Qlucore, leading software provider of visualization-based software for research-oriented data analysis and precision diagnostics, has launched Qlucore Omics Explorer (QOE) version 3.9. The new version provides statistical test results up to 900 times faster.
    Full story
  • AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs

    May 5, 2023, 16:29 PM by
    AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework Project will ensure digital clinical measures and products meet the needs of larger audiences.
    Full story
  • Clearwater Launches New Branding and Website Affirming its Continued Commitment to Serving the Cybersecurity and Compliance Needs of the Healthcare Industry

    May 5, 2023, 16:29 PM by
    Clearwater today launched a new website and brand identity to reflect the company’s mission of serving the needs of the entire healthcare ecosystem following its acquisitions of TECH LOCK and CynergisTek. It’s no secret that healthcare organizations need a strong cybersecurity and compliance partner now more than ever, and the combined company provides a deep pool of experts across a broad range of cybersecurity, privacy, and compliance domains.
    Full story
  • CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor

    May 5, 2023, 16:29 PM by
    CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor Registration for must-attend Risk-Based Quality Management event is now open
    Full story
  • Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics

    May 5, 2023, 16:29 PM by
    Arranta Bio, part of Recipharm’s biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics.
    Full story
  • 2bPrecise Named “Best Overall Genomics Company” by MedTech Breakthrough

    May 5, 2023, 16:29 PM by
    Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies
    Full story
  • MultiOmic Health closes $6.2 million funding round to discover precision medicines for metabolic syndrome-related conditions

    May 5, 2023, 16:29 PM by
    MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, has closed a £5 million (US$6.2 million) seed funding extension round to build its precision therapeutics discovery platform for metabolic syndrome-related medical conditions.
    Full story
  • New Talent Equity® Report shows how life sciences organisations are using hybrid working to their advantage

    May 5, 2023, 16:29 PM by
    The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: No turning back – an analysis of the hybrid working models that have emerged from the pandemic and how they have enabled positive changes to leadership, team dynamics and recruitment and retention of talent in the life science sector.
    Full story
  • FDB Vela™ Leader to Share Vision for Vastly Reducing Fill Times for Specialty Drug ePrescribing at NCPDP Annual Conference

    May 5, 2023, 16:29 PM by
    FDB Vela™ Leader to Share Vision for Vastly Reducing Fill Times for Specialty Drug ePrescribing at NCPDP Annual Conference
    Full story
  • BOC Sciences Reports Strong Capabilities of CDMO Operations

    May 5, 2023, 16:29 PM by
    BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.
    Full story
  • BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development

    May 5, 2023, 16:29 PM by
    BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.
    Full story
  • Accelerating Implementation: Unlocking the Potential of Next-Generation Sequencing

    May 5, 2023, 01:00 AM by User Not Found
    Bio-IT World | Next-generation sequencing (NGS) has revolutionized molecular biology and served as a universal tool for many research avenues across the spectrum of biology. With the NGS market expanding, three key barriers—time, cost, and expertise—are holding back the potential of NGS and the full impact it could have on society, diagnostics, and precision medicine.
    Full story
  • Anastasia Christianson on Pfizer’s Approach to AI, ML, and the Digital Age

    May 4, 2023, 13:24 PM by User Not Found
    Bio-IT World | At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Bio-Team co-founder Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson will be the opening keynote at the 2023 Bio-IT World Conference & Expo, May 16-18, 2023, in Boston.
    Full story
  • Novel Mouse Avatars Could Advance Personalized Medicine For Cancer

    May 3, 2023, 01:00 AM by User Not Found
    Bio-IT World | Up to now, mouse avatars haven’t proven to be particularly good tools for forecasting treatment response in human cancer patients. But new models being generated by an international team of researchers are expected to be far more predictive of what is going to happen with different cohorts of clinical trial participants.
    Full story
  • Oxford Nanopore Targets Diagnostics, New Products from Vizgen, Agilent, More

    Apr 27, 2023, 01:00 AM by User Not Found
    Bio-IT World | Ginkgo Bioworks acquires an adeno-associated virus capsid discovery and engineering platform; Oxford Nanopore Technologies and bioMérieux SA have teamed up bring nanopore sequencing to the infectious disease diagnostics market, and the emergency of Large Language Models ops. Plus, new products from Metabolon, Cytiva, Vizgen, Agilent, and more.
    Full story
  • PEACE Study Offers New Clues About How Cancer Resists Treatment

    Apr 26, 2023, 01:00 AM by User Not Found
    Bio-IT World | Research autopsies are nothing new—the use of post-mortem tissues for cancer research has been ongoing since the end of the nineteenth century—but the Cancer Research UK-sponsored PEACE (posthumous evaluation of advanced cancer environment) study stands apart by virtue of its scope and scale. The pan-cancer initiative intends to enroll 500 patients across the country in hopes of understanding cancer evolution, drug resistance and why patients die of their disease.
    Full story
  • It Turns out that p53 is Destroyed in a Whole New Way

    Apr 25, 2023, 11:39 AM by
    CSHL scientists have discovered that a protein called BRD8 goes out of control in glioblastoma, paralyzing P53. The discovery could help turn this deadly cancer into a treatable disease.
    Full story
  • Crispr/Cas9 Platform Developed Maize Mutant Library Covering 800 Functional Genes with CRISPR/Cas9 Technology

    Apr 25, 2023, 11:39 AM by
    Full story
  • Microbialtec Utilized Two Methods to Achieve Pseudomonas Aeruginosa Genome Editin

    Apr 25, 2023, 11:39 AM by
    Full story
  • «
  • 81
  • 82
  • 83 (current)
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy